Patients with chronic kidney disease (CKD) are at very high risk of heart disease. Statins have been shown to decrease cholesterol levels and mortality in the general population. The aim of this review was to analyse if a similar effect could be shown in patients with non‐dialysis dependent CKD. This review identified 26 completed studies (25,017 patients). Statins decreased all‐cause mortality and cardiovascular mortality along with lowering lipid levels to an extent which is similar to that found in the general population. Statins also reduce protein excretion in urine but the impact of this on the risk of needing renal replacement therapy needs to be studied further. Statins were not found to have serious adverse effects in this group of people.
- kidney disease
- heart disease
Navaneethan, S. D., Pansini, F., Perkovic, V., Manno, C., Pellegrini, F., Johnson, D. W., Craig, J. C., & Strippoli, G. F. M. (2009). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, (2), [CD007784]. https://doi.org/10.1002/14651858.CD007784